Medical Devices Startups
6,223 companies tagged Medical Devices, with their investors and founders.
IDEXX develops diagnostic and software products for veterinary clinics, livestock and dairy operations, and water quality testing. The company serves the global animal health, food safety, and public health sectors with point-of-care and laboratory diagnostic solutions.
2 investors
IDUN Technologies develops brain-computer interface devices that collect and process cognitive and emotional data to promote wellbeing. The company serves research institutions and commercial partners applying neurotechnology for observation, diagnosis, intervention, and wellness applications.
2 investors
A cardiovascular cell-based product designed to improve heart function through cytokine secretion and long-term engraftment via blood vessel formation and circulation.
2 investors
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.
2 investors
Illumicell develops AI-driven tools for early diagnosis and clinical decision support in healthcare, with a focus on deploying solutions in hospital settings. The company combines advanced artificial intelligence with cloud infrastructure and high-performance computing to deliver clinically meaningful solutions for medical specialties.
2 investors
Illumi Medical is a medical device company based in Japan with research facilities in Nagoya and Koriyama. The page provides company contact and location information but does not specify the company's product offerings or business focus.
2 investors
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
2 investors
Immersive Labz builds immersive medical education solutions, including Cadaviz, a virtual human dissection platform that enables learners to visualize and study detailed 3D anatomical models for gross anatomy, radiology, histology, and clinical applications. The company serves medical institutions, educators, and healthcare learners globally seeking to modernize anatomy and clinical education.
2 investors
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments. The company is an ETH Zürich spin-off focused on precision medicine and gene editing approaches for genetic disease intervention.
2 investors
ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.
2 investors
Immuneel Therapeutics develops and manufactures cell-based immunotherapies, including CAR-T therapies, for cancer patients, with in-house cGMP lentiviral vector manufacturing. The company aims to make next-generation cell therapies affordable and accessible in India, with a global outlook.
2 investors
Immunito AI is an in-silico antibody discovery company that combines artificial intelligence with an in-house biological lab to speed up and improve the discovery of antibodies. It serves the biotech and biopharmaceutical industry.
2 investors
NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
2 investors
Immunomic Therapeutics develops nucleic acid immunotherapy platforms, particularly self-amplifying RNA and plasmid DNA vaccines, for cancer treatment, allergies, and animal health applications. The company's UNITE® platform leverages lysosomal targeting technology to generate immune responses against CMV, HPV, and other tumor-associated antigens across multiple cancer types and allergic conditions.
2 investors
Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.
2 investors
Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
2 investors
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
2 investors
Inception Fertility is a holding company operating a network of fertility brands providing comprehensive reproductive care including IVF clinics, egg and sperm banking, financing, pharmacy, and wellness services. The company serves patients and families navigating fertility treatment across North America.
2 investors
Indomo Tx develops drug delivery technology focused on dermatology and consumer health, aiming to improve patient outcomes by helping individuals manage their own health. It is backed by a team with expertise in drug delivery, dermatology, and clinical and pharmaceutical fields.
2 investors
Infera builds a compliance and quality engineering platform for medical device manufacturers, using AI agents to automate regulatory and quality processes. The platform serves medtech teams bringing life-saving devices to market.
2 investors
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization. The company serves pharmaceutical and biotech partners developing treatments across 350+ disease targets.
2 investors
Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.
2 investors
InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes. The company specializes in radiation oncology dose prediction, with their RadOncAI platform designed to optimize head and neck radiation therapy planning while reducing exposure to healthy tissues.
2 investors
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
2 investors